Citation Impact
Citing Papers
TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting
2014
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
2016
Microbiota in health and diseases
2022 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Necroinflammation in Kidney Disease
2015
Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice
2011
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
2020 Standout
Global epidemiology and outcomes of acute kidney injury
2018 Standout
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
IL-6 as a keystone cytokine in health and disease
2015 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Application potential of toll-like receptors in cancer immunotherapy
2016
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
2013
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Acute kidney injury
2021 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Structure–function relationships of immunostimulatory polysaccharides: A review
2015 Standout
Inflammation in AKI
2015
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Regulation of immune responses by extracellular vesicles
2014 Standout
SNAPIN: an endogenous toll-like receptor ligand in rheumatoid arthritis
2012
The microbiome and cancer
2013
Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
2013
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
2019
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
2018
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Dietary Fiber Pectin Directly Blocks Toll-Like Receptor 2–1 and Prevents Doxorubicin-Induced Ileitis
2018
Accumulation of Somatic Mutations in TP53 in Gastric Epithelium With Helicobacter pylori Infection
2014
The history of Toll-like receptors — redefining innate immunity
2013
Neutrophils in cancer: neutral no more
2016 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
2015
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
2018
Toll-Like Receptors and Cancer, Particularly Oral Squamous Cell Carcinoma
2014
Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis
2014
DAMP-TLR-cytokine axis dictates the fate of tumor
2017
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Microglia in Alzheimer’s disease
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment
2015
Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse
2015
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
2016
Inflammasomes as therapeutic targets for A lzheimer's disease
2016
Innate immunity as a target for acute cardioprotection
2018
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
2015 StandoutNobel
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
2017
Danger Signals in the Initiation of the Inflammatory Response after Myocardial Infarction
2013
Toll-like Receptors from the Perspective of Cancer Treatment
2020
Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
2018 StandoutNobel
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
2020
Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
2013
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
2017
Works of William McCormack being referenced
Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
2011
Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease
2016
Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer
2017
Toll-like receptors and NOD-like receptors in rheumatic diseases
2009
Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
2013
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
2012
Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia‐reperfusion injury
2011
Treatment With OPN-305, a Humanized Anti–Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
2012